WS #11745

From 499 msgs · 7 key-dev
Holding: newest synthesis is 135d old

AstraZeneca's Wainua (eplontersen) fails Phase 3 trial in transthyretin-mediated amyloid cardiomyopathy, stock falls 6.2%.

AstraZeneca Drug Trial Failure

AstraZeneca's Wainua (eplontersen) fails Phase 3 trial in transthyretin-mediated amyloid cardiomyopathy, stock falls 6.2%.

Full world state #11745 →